InvestorsHub Logo
Followers 4
Posts 75
Boards Moderated 1
Alias Born 08/05/2013

Re: None

Friday, 01/23/2015 5:38:32 PM

Friday, January 23, 2015 5:38:32 PM

Post# of 10
Curis will be developing small-molecule compounds that can be administered via a pill, rather than nearly all other immune-oncology drugs, which typically must be injected or infused.


http://m.bizjournals.com/boston/blog/bioflash/2015/01/curis-aims-for-anti-cancer-drugs-that-use-the.html?r=full

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.